Conference
208 HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: results of a phase I trial
Authors
Hotte SJ; Oza AM; Le LH; MacLean M; Iacobucci A; Corey A; Fox NL; Hirte HW
Volume
2
Publisher
Elsevier
Publication Date
September 2004
DOI
10.1016/s1359-6349(04)80216-7
Conference proceedings
European Journal of Cancer Supplements
Issue
8
ISSN
1359-6349